Literature DB >> 11475014

Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta.

H Kölsch1, M Ludwig, D Lütjohann, M L Rao.   

Abstract

24-Hydroxycholesterol, the main cholesterol elimination product of the brain is increased in serum of Alzheimer patients. This oxysterol behaves neurotoxic towards the human neuroblastoma cell line, SH-SY5Y. Here we demonstrate, that 24-hydroxycholesterol-induced neurotoxicity in differentiated SH-SY5Y cells was due to apoptosis, as indicated by DNA-fragmentation, caspase-3 activation and a decrease of the mitochondrial membrane potential. Free radicals were generated, resulting in the death of 75% of the cells within 48h; neurotoxicity in differentiated SH-SY5Y cells was partially prevented by physiological concentrations of vitamin E (50-100 microM) in that 75% of the cells survived. Physiological concentrations of estradiol-17beta (1-100nM) elicited a protective effect in differentiated cells, which was not significant; however, in undifferentiated cells a significant protection was noted by this steroid hormone. Vitamin C and melatonin did not prevent 24-hydroxycholesterol-induced neurotoxicity. These in vitro data support the in vivo observed beneficial effects reported as circumstantial evidence of vitamin E and estradiol-17beta treatment in the prevention and therapy of neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11475014     DOI: 10.1007/s007020170068

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  17 in total

Review 1.  Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Karen Berman; Henry Brodaty
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

2.  Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary.

Authors:  S Helisalmi; S Vepsäläinen; A M Koivisto; A Mannermaa; S Iivonen; M Hiltunen; V Kiviniemi; H Soininen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

Review 3.  Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.

Authors:  Vincenzo Giordano; Gianfranco Peluso; Maurizio Iannuccelli; Paola Benatti; Raffaella Nicolai; Menotti Calvani
Journal:  Neurochem Res       Date:  2006-08-17       Impact factor: 3.996

4.  Effects of cholesterol and its 24S-OH and 25-OH oxysterols on choline acetyltransferase-positive neurons in brain slices.

Authors:  Celine Ullrich; Michael Pirchl; Christian Humpel
Journal:  Pharmacology       Date:  2010-06-23       Impact factor: 2.547

5.  A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice.

Authors:  Dacheng Peng; Richard A Hiipakka; Jing-Tian Xie; Qing Dai; John M Kokontis; Catherine A Reardon; Godfrey S Getz; Shutsung Liao
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

6.  The influence of age of lead exposure on adult gray matter volume.

Authors:  Christopher J Brubaker; Kim N Dietrich; Bruce P Lanphear; Kim M Cecil
Journal:  Neurotoxicology       Date:  2010-03-11       Impact factor: 4.294

7.  Modulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balance.

Authors:  M Cristina Polidori; Ludger Pientka; Gereon Nelles; Helen R Griffiths
Journal:  Int J Clin Exp Med       Date:  2010-04-20

8.  Oxysterol-induced toxicity in R28 and ARPE-19 cells.

Authors:  John M Ong; Annette M Aoki; Gail M Seigel; Ingrid Sacerio; Raquel Castellon; Anthony B Nesburn; M Cristina Kenney
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

9.  Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress.

Authors:  Patricia Ferrera; Octavio Mercado-Gómez; Martín Silva-Aguilar; Mahara Valverde; Clorinda Arias
Journal:  Neurochem Res       Date:  2008-02-21       Impact factor: 3.996

10.  Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells.

Authors:  Bhanu Dasari; Jaya R P Prasanthi; Craig Meiers; Brij B Singh; Othman Ghribi
Journal:  Curr Eye Res       Date:  2013-07-10       Impact factor: 2.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.